Saluda Medical
Founded Year
2011Stage
Series G - II | AliveTotal Raised
$502.65MLast Raised
$100M | 2 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-29 points in the past 30 days
About Saluda Medical
Saluda Medical focuses on neuromodulation therapies within the healthcare sector, specializing in advanced closed-loop technologies for treating neurological disorders. The company's flagship product, the Evoke System, is a spinal cord stimulation device that utilizes ECAP-controlled closed-loop technology to manage chronic intractable pain, including conditions associated with failed back surgery syndrome and various types of leg and back pain. The Evoke System has been subjected to clinical trials. It was founded in 2011 and is based in Minneapolis, Minnesota.
Loading...
Loading...
Research containing Saluda Medical
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Saluda Medical in 2 CB Insights research briefs, most recently on Jul 26, 2023.
Jul 26, 2023 report
State of Digital Health Q2’23 Report
Expert Collections containing Saluda Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Saluda Medical is included in 1 Expert Collection, including Digital Health.
Digital Health
11,250 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Saluda Medical Patents
Saluda Medical has filed 127 patents.
The 3 most popular patent topics include:
- implants (medicine)
- neurophysiology
- neurotechnology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/9/2021 | 11/12/2024 | Neurophysiology, Neurotechnology, Neuroscience, Neurological disorders, Implants (medicine) | Grant |
Application Date | 11/9/2021 |
|---|---|
Grant Date | 11/12/2024 |
Title | |
Related Topics | Neurophysiology, Neurotechnology, Neuroscience, Neurological disorders, Implants (medicine) |
Status | Grant |
Latest Saluda Medical News
Jan 13, 2025
Saluda Medica l , a Minneapolis, MN-based commercial-stage medical device company, raised $100M in funding. The round was led by Redmile Group, with participation from existing investors Wellington Management, TPG Life Sciences Innovation, Fidelity Management & Research Company, Action Potential Venture Capital, and funds and accounts advised by T. Rowe Price Associates, Inc. New investor Piper Heartland Healthcare Capital also participated. The company intends to use the funds to advance the commercialization of the Evoke® System, the first commercial application of its proprietary closed-loop, dose-control neuromodulation platform. Saluda Medical is a commercial-stage medical device company focused on developing treatments for chronic neurological conditions driven by a novel neuromodulation platform, which is designed to sense and measure neural responses to stimulation and automatically adjust therapy based on real-time neurophysiological feedback. Its first product, the Evoke® System, is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. FinSMEs
Saluda Medical Frequently Asked Questions (FAQ)
When was Saluda Medical founded?
Saluda Medical was founded in 2011.
Where is Saluda Medical's headquarters?
Saluda Medical's headquarters is located at 9401 James Avenue South, Minneapolis.
What is Saluda Medical's latest funding round?
Saluda Medical's latest funding round is Series G - II.
How much did Saluda Medical raise?
Saluda Medical raised a total of $502.65M.
Who are the investors of Saluda Medical?
Investors of Saluda Medical include Redmile Group, Action Potential Venture Capital, Fidelity Investments, Wellington Management, T. Rowe Price and 9 more.
Who are Saluda Medical's competitors?
Competitors of Saluda Medical include Nevro.
Loading...
Compare Saluda Medical to Competitors
Micron Medical specializes in minimally invasive medical devices for pain management and neuromodulation. The company offers products like the MiniStim PNS System, which provides non-drug pain therapy through wireless neurostimulation technology. These devices are designed to treat chronic pain in various parts of the body, including the knee, hip, and SI joint, and are used in clinical studies to explore treatment options for conditions like Diabetic Peripheral Neuropathy. Micron Medical was formerly known as StimGuard. It was founded in 2019 and is based in Boca Raton, Florida.
SPR Therapeutics specializes in pain management solutions within the medical device industry. The company offers the SPRINT PNS System, a non-permanent, minimally invasive treatment designed to provide long-term relief from chronic and acute pain through peripheral nerve stimulation. It primarily serves the healthcare sector, offering solutions to both physicians and patients dealing with pain management. It was founded in 2010 and is based in Cleveland, Ohio.
Mainstay Medical focuses on the medical device industry, specifically in the area of restorative neurostimulation. The company's primary product is a restorative therapy device that stimulates the nerves of the muscle responsible for stabilizing the lumbar spine, aiming to interrupt the cycle of low back pain, degeneration, and loss of function. Mainstay Medical primarily serves the healthcare sector, particularly patients suffering from chronic low back pain. It was founded in 2008 and is based in San Diego, California.
Bioness offers medical devices designed to benefit people with stroke, Multiple Sclerosis, traumatic brain injury, Cerebral Palsy, and spinal cord injury. These products use electrical stimulation to help people regain mobility and independence and to improve their quality of life and productivity. The company was founded in 1992 and is based in Valencia, California.
ReFlow Medical develops medical devices for the treatment of cardiovascular diseases within the healthcare industry. The company provides products for vascular interventions, including devices for treating peripheral and coronary artery conditions. ReFlow Medical serves the healthcare sector, focusing on medical professionals and hospitals. It is based in San Clemente, California.
NeuroSigma operates as a bioelectronics company focused on developing medical devices for neurological and neuropsychiatric disorders. Its main product, the Monarch eTNS System, is a non-invasive device designed to treat pediatric Attention Deficit Hyperactivity Disorder (ADHD) through external trigeminal nerve stimulation. It is primarily used in the home setting under caregiver supervision during sleep. It was founded in 2008 and is based in Los Angeles, California.
Loading...